Ros Matthew 4
4 · Cogent Biosciences, Inc. · Filed Jul 5, 2022
Insider Transaction Report
Form 4
Ros Matthew
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-07-01$5.87/sh+2,194$12,880→ 2,194 totalExercise: $9.39From: 2022-07-01Exp: 2032-07-01→ Common Stock (2,194 underlying)
Footnotes (1)
- [F1]The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant.